Clear Harbor Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Buy |
3,555
+30
| +0.9% | +$3.8K | 0.03% | 283 |
|
|
2025
Q1 | $451K | Buy |
3,525
+380
| +12% | +$48.6K | 0.04% | 275 |
|
|
2024
Q4 | $416K | Buy |
3,145
+40
| +1% | +$5.29K | 0.03% | 256 |
|
|
2024
Q3 | $452K | Hold |
3,105
| – | – | 0.04% | 239 |
|
|
2024
Q2 | $426K | Sell |
3,105
-717
| -19% | -$98.4K | 0.04% | 239 |
|
|
2024
Q1 | $524K | Buy |
3,822
+129
| +3% | +$17.7K | 0.05% | 215 |
|
|
2023
Q4 | $502K | Sell |
3,693
-996
| -21% | -$135K | 0.05% | 207 |
|
|
2023
Q3 | $573K | Sell |
4,689
-139
| -3% | -$17K | 0.06% | 190 |
|
|
2023
Q2 | $613K | Sell |
4,828
-341
| -7% | -$43.3K | 0.06% | 189 |
|
|
2023
Q1 | $668K | Buy |
5,169
+390
| +8% | +$50.4K | 0.07% | 195 |
|
|
2022
Q4 | $627K | Hold |
4,779
| – | – | 0.08% | 182 |
|
|
2022
Q3 | $559K | Buy |
4,779
+725
| +18% | +$84.8K | 0.08% | 177 |
|
|
2022
Q2 | $477K | Buy |
4,054
+293
| +8% | +$34.5K | 0.06% | 216 |
|
|
2022
Q1 | $490K | Buy |
3,761
+1,963
| +109% | +$256K | 0.06% | 220 |
|
|
2021
Q4 | $274K | Buy |
+1,798
| New | +$274K | 0.03% | 304 |
|
|
2020
Q4 | – | Sell |
-330
| Closed | -$44.7K | – | 484 |
|
|
2020
Q3 | $44.7K | Buy |
+330
| New | +$44.7K | 0.01% | 398 |
|
|
2020
Q1 | – | Sell |
-345
| Closed | -$41.6K | – | 440 |
|
|
2019
Q4 | $41.6K | Buy |
+345
| New | +$41.6K | 0.01% | 424 |
|